Regulation of HOX gene expression in AML
- PMID: 38453907
- PMCID: PMC10920644
- DOI: 10.1038/s41408-024-01004-y
Regulation of HOX gene expression in AML
Abstract
As key developmental regulators, HOX cluster genes have varied and context-specific roles in normal and malignant hematopoiesis. A complex interaction of transcription factors, epigenetic regulators, long non-coding RNAs and chromatin structural changes orchestrate HOX expression in leukemia cells. In this review we summarize molecular mechanisms underlying HOX regulation in clinical subsets of AML, with a focus on NPM1 mutated (NPM1mut) AML comprising a third of all AML patients. While the leukemia initiating function of the NPM1 mutation is clearly dependent on HOX activity, the favorable treatment responses in these patients with upregulation of HOX cluster genes is a poorly understood paradoxical observation. Recent data confirm FOXM1 as a suppressor of HOX activity and a well-known binding partner of NPM suggesting that FOXM1 inactivation may mediate the effect of cytoplasmic NPM on HOX upregulation. Conversely the residual nuclear fraction of mutant NPM has also been recently shown to have chromatin modifying effects permissive to HOX expression. Recent identification of the menin-MLL interaction as a critical vulnerability of HOX-dependent AML has fueled the development of menin inhibitors that are clinically active in NPM1 and MLL rearranged AML despite inconsistent suppression of the HOX locus. Insights into context-specific regulation of HOX in AML may provide a solid foundation for targeting this common vulnerability across several major AML subtypes.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures

Similar articles
-
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia.Cancer Discov. 2016 Oct;6(10):1166-1181. doi: 10.1158/2159-8290.CD-16-0237. Epub 2016 Aug 17. Cancer Discov. 2016. PMID: 27535106 Free PMC article.
-
Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias.Leukemia. 2007 Sep;21(9):2000-9. doi: 10.1038/sj.leu.2404808. Epub 2007 Jun 28. Leukemia. 2007. PMID: 17597811
-
HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling.Anticancer Res. 2025 May;45(5):2079-2089. doi: 10.21873/anticanres.17582. Anticancer Res. 2025. PMID: 40295061
-
Molecular leveraging of HOX-embedded non-coding RNAs in the progression of acute myeloid leukemia.Hum Cell. 2024 Nov 30;38(1):24. doi: 10.1007/s13577-024-01149-9. Hum Cell. 2024. PMID: 39614990 Review.
-
NPM1-mutated acute myeloid leukemia: New pathogenetic and therapeutic insights and open questions.Am J Hematol. 2023 Sep;98(9):1452-1464. doi: 10.1002/ajh.26989. Epub 2023 Jun 15. Am J Hematol. 2023. PMID: 37317978 Review.
Cited by
-
How to put a hex on HOX.Hemasphere. 2024 Jun 3;8(6):e83. doi: 10.1002/hem3.83. eCollection 2024 Jun. Hemasphere. 2024. PMID: 38836099 Free PMC article. No abstract available.
-
Successful cord blood transplantation for a unique case of bone marrow failure presenting t(2;19)(p23;q13.3) translocation suggesting disruption of DPY30.Fukushima J Med Sci. 2025 Apr 19;71(2):129-134. doi: 10.5387/fms.24-00044. Epub 2025 Feb 8. Fukushima J Med Sci. 2025. PMID: 39909446 Free PMC article.
-
Mutant IDH1 cooperates with NPM1c or FLT3ITD to drive distinct myeloid diseases and molecular outcomes.Proc Natl Acad Sci U S A. 2025 May 20;122(20):e2415779122. doi: 10.1073/pnas.2415779122. Epub 2025 May 16. Proc Natl Acad Sci U S A. 2025. PMID: 40377995
-
Enhancer Hijacking Discovery in Acute Myeloid Leukemia by Pyjacker Identifies MNX1 Activation via Deletion 7q.Blood Cancer Discov. 2025 Jul 1;6(4):343-363. doi: 10.1158/2643-3230.BCD-24-0278. Blood Cancer Discov. 2025. PMID: 40162972 Free PMC article.
-
Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead.J Hematol Oncol. 2024 Nov 18;17(1):113. doi: 10.1186/s13045-024-01632-8. J Hematol Oncol. 2024. PMID: 39558390 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous